Medtronic has gained European CE mark approval for its next-generation Micra leadless pacemakers, the Micra AV2 and Micra VR2 transcatheter pacing systems. Both devices gained U.S. Food and Drug Administration…

Researchers have developed a reusable vest capable of mapping the heart’s electrical activity in just five minutes, sharing their findings in the Journal of Cardiovascular Magnetic Resonance.[1]. The group—made up of cardiologists and…

The Food and Drug Administration (FDA) this week cleared a pulsed field ablation (PFA) system, the Medtronic PulseSelect System, for the treatment of both paroxysmal and persistent atrial fibrillation (AF). The approval is the first for this…

Transcatheter aortic valve replacement (TAVR) patients face a heightened risk of adverse short- and long-term outcomes if they present with preexisting…

Ajax Health, a California-based venture capital firm, has launched a new healthcare company focused on atrial fibrillation (AFib) ablation technology. The new entity, Cortex, has already raised $90 million in funding as it enters the market.…

The American College of Cardiology (ACC) and American Heart Association (AHA) just published…

The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines for the diagnosis and management of atrial fibrillation (AFib).…

The bodies of organ donors are regularly treated with thyroid hormones to preserve heart function and ensure any transplant procedures are a success. However, a new study published in The New England Journal of Medicine suggests those…

Johnson & Johnson MedTech has acquired Laminar, a California-based healthcare technology company known for its investigational left atrial appendage (LAA) elimination technology, for $400 million. The deal could also include additional…

Medtronic has added a new device, the Penditure Left Atrial Appendage (LAA) Exclusion System, to its cardiac surgery portfolio. The device was designed for the exclusion of the LAA in patients undergoing concomitant heart surgeries, a step…

Bayer has ended a clinical trial for its new atrial fibrillation (AFib) drug much earlier than planned based on recommendations from the Independent Data Monitoring Committee (IDMC). OCEANIC-…

Medtronic has gained European CE mark approval for its PulseSelect Pulsed Field Ablation (PFA) System and the Nitron CryoConsole.

PulseSelect, designed to treat atrial fibrillation (AFib), is a key piece of Medtronic’s cardiac ablation…

The use of artificial intelligence (AI) to evaluate and treat heart disease has been one of the biggest stories at the…

The International Liaison Committee on Resuscitation (ILCOR), a global group focused on improving patient outcomes after in-hospital cardiac arrest (IHCA), has shared 10 steps hospitals can take to improve the…

Treating paroxysmal atrial fibrillation (AFib) with a next-generation radiofrequency (RF) catheter from Biosense Webster, a Johnson and Johnson MedTech company, is associated with significant improvements in quality of life (QOL), according to…

Researchers from Google have introduced a new approach for cardiac monitoring that relies on the active noise canceling (ANC) technology found in headphones and earbuds.

The technique, audioplethysmography (APG), can monitor a user’s…

Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was…

Transcatheter aortic valve replacement (TAVR) has been one of the hottest topics in…

Medtronic has gained U.S. Food and Drug Administration (FDA) approval for a new first-of-its-kind extravascular implantable cardioverter-defibrillator (ICD) and defibrillation lead that allows cardiologists to…